Harrington William T's Form 4 filing
Mobia Medical, Inc. (MOBI) · filed May 11, 2026
- Accession no.
- 0001628280-26-033811
- Filed
- May 11, 2026
- Trade date
- Jan 30-May 11, 2026
- Filing delay
- 101 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 8 derivative transactions. Open-market purchases total $8.00M. It was filed 101 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Harrington William TCIK 0001256742 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | CConversionAcquired | +284,324 | –F1 | – | 284,324 | Indirect | |
| May 11, 2026 | Common Stock | CConversionAcquired | +264,746 | –F1 | – | 264,746 | Indirect | |
| May 11, 2026 | Common Stock | CConversionAcquired | +1,455,726 | –F4 | – | 1,740,050 | Indirect | |
| May 11, 2026 | Common Stock | CConversionAcquired | +872,770 | –F4 | – | 1,137,516 | Indirect | |
| May 11, 2026 | Common Stock | PPurchaseAcquired | +266,666 | $15.00 | +$3,999,990 | 2,006,716 | Indirect | |
| May 11, 2026 | Common Stock | PPurchaseAcquired | +266,667 | $15.00 | +$4,000,005 | 1,404,183 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Common Stock | AGrant or awardAcquired | +284,324 | $3,411,892.25 | +$11,641,008,725,610.06 | 3,411,892.25 | Indirect | Price outlier |
| Jan 30, 2026 | Common Stock | AGrant or awardAcquired | +264,746 | $3,176,955.03 | +$10,093,043,262,642.3 | 3,176,955.03 | Indirect | Price outlier |
| May 7, 2026 | Common Stock | AGrant or awardAcquired | +31,520 | $0.00 | $0 | 31,520 | Direct | |
| May 11, 2026 | Common Stock | CConversionDisposed | −284,324 | –F1 | – | 0 | Indirect | |
| May 11, 2026 | Common Stock | CConversionDisposed | −264,746 | –F1 | – | 0 | Indirect | |
| May 11, 2026 | Common Stock | CConversionDisposed | −1,128,438 | –F4 | – | 0 | Indirect | |
| May 11, 2026 | Common Stock | CConversionDisposed | −327,288 | –F4 | – | 0 | Indirect | |
| May 11, 2026 | Common Stock | CConversionDisposed | −872,770 | –F4 | – | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the "Offering"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes.
Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.
- F4
Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms.
Referenced by the price of 2 transactions in Table I and 3 transactions in Table II.